ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
3.650
+0.080 (2.24%)
Nov 21, 2024, 1:19 PM EST - Market open
ImmuCell Revenue
ImmuCell had revenue of $6.01M in the quarter ending September 30, 2024, with 11.40% growth. This brings the company's revenue in the last twelve months to $23.84M, up 46.37% year-over-year. In the year 2023, ImmuCell had annual revenue of $17.47M, down -5.90%.
Revenue (ttm)
$23.84M
Revenue Growth
+46.37%
P/S Ratio
1.19
Revenue / Employee
$301,747
Employees
79
Market Cap
28.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 17.47M | -1.10M | -5.90% |
| Dec 31, 2022 | 18.57M | -675.01K | -3.51% |
| Dec 31, 2021 | 19.24M | 3.90M | 25.43% |
| Dec 31, 2020 | 15.34M | 1.62M | 11.80% |
| Dec 31, 2019 | 13.72M | 2.74M | 24.91% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 135.57M |
| IRIDEX | 48.43M |
| Surrozen | 10.00M |
| DURECT | 8.59M |
| Marker Therapeutics | 5.40M |
| SAB Biotherapeutics | 1.51M |
| OneMedNet | 1.02M |
| Pluri | 598.00K |
ICCC News
- 7 days ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 14 days ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 6 weeks ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - GlobeNewsWire
- 3 months ago - ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire